Discrepant serological findings in SARS‐CoV‐2 PCR‐negative hospitalized patients with fever and acute respiratory symptoms during the pandemic
Open Access
- 12 March 2022
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (6) , 2460-2470
Abstract
Background COVID-19 serology has an evolving role in the diagnosis of SARS-CoV-2 infection. However, its use in hospitalised patients with acute respiratory symptoms remains unclear. Methods Hospitalised patients with acute respiratory illness admitted to an isolation ward were recruited. All patients had negative nasopharyngeal swab polymerase chain reaction (PCR) for SARS-CoV-2. Serological studies using 4 separate assays (cPass: surrogate neutralising ELISA; Elecsys: N-antigen based chemiluminescent assay; SFB: S protein flow-based; epitope peptide-based ELISA;) were performed on stored plasma collected from patients during the initial hospital stay, and a convalescent visit 4-12 weeks later. Results Of the 51 patients studied (aged 54, IQR 21-84; 62.7% male), no patients tested positive on the Elecsys or cPass assays. 5/51 patients had antibodies detected on B-cell Epitope Assay, and 3/51 had antibodies detected on SFB assay. These 8 patients with positive serological test to COVID-19 were more likely to have a high-risk occupation (p=0.039), bacterial infection (p=0.028) and neutrophilia (p=0.013) during their initial hospital admission. Conclusion Discrepant COVID-19 serological findings were observed amongst those with recent hospital admissions and bacterial infections. The positive serological findings within our cohort raise important questions about the interpretation of sero-epidemiology during the current pandemic.Keywords
This publication has 37 references indexed in Scilit:
- Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since ExposureAnnals of Internal Medicine, 2020
- Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease PatientsEmerging Infectious Diseases, 2020
- Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore — January 2–February 29, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Interrupting transmission of COVID-19: lessons from containment efforts in SingaporeJournal of Travel Medicine, 2020
- Polyclonal B cell activation in infections: infectious agents’ devilry or defense mechanism of the host?Journal of Leukocyte Biology, 2007
- SARS Transmission and Hospital ContainmentEmerging Infectious Diseases, 2004
- Severe acute respiratory syndrome--Singapore, 2003.2003
- Lymphocyte Polyclonal Activation: A Pitfall for Vaccine Design against Infectious AgentsParasitology Today, 2000
- Autoimmunity, Polyclonal B-Cell Activation and InfectionLupus, 1992